Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world treatment practice in patients with advanced melanoma.
Cybulska-Stopa B, Piejko K, Pacholczak R, Domagała-Haduch M, Drosik-Kwaśniewska A, Rolski J, Wiktor-Mucha P, Zemełka T. Cybulska-Stopa B, et al. Among authors: zemelka t. Contemp Oncol (Pozn). 2020;24(2):118-124. doi: 10.5114/wo.2020.97607. Epub 2020 Jul 3. Contemp Oncol (Pozn). 2020. PMID: 32774137 Free PMC article.
Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients.
Cybulska-Stopa B, Ziętek M, Kamińska-Winciorek G, Czarnecka AM, Piejko K, Galus Ł, Ziółkowska B, Kieszko S, Kempa-Kamińska N, Calik J, Zemełka T, Kubiatowski T, Suwiński R, Mackiewicz J, Rutkowski P. Cybulska-Stopa B, et al. Among authors: zemelka t. Melanoma Res. 2021 Feb 1;31(1):49-57. doi: 10.1097/CMR.0000000000000705. Melanoma Res. 2021. PMID: 33165240
Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma.
Cybulska-Stopa B, Ziętek M, Czarnecka AM, Piejko K, Dziura R, Galus Ł, Ziółkowska B, Kieszko S, Kempa-Kamińska N, Calik J, Seredyńska J, Gądek K, Zemełka T, Teterycz P, Kubiatowski T, Suwiński R, Mackiewicz J, Rutkowski P. Cybulska-Stopa B, et al. Among authors: zemelka t. J Dermatolog Treat. 2022 Jun;33(4):2168-2174. doi: 10.1080/09546634.2021.1937477. Epub 2021 Jun 14. J Dermatolog Treat. 2022. PMID: 34057374 Free article.
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence.
Rogala P, Czarnecka AM, Cybulska-Stopa B, Ostaszewski K, Piejko K, Ziętek M, Dziura R, Rutkowska E, Galus Ł, Kempa-Kamińska N, Calik J, Sałek-Zań A, Zemełka T, Bal W, Kamycka A, Świtaj T, Kamińska-Winciorek G, Suwiński R, Mackiewicz J, Rutkowski P. Rogala P, et al. Among authors: zemelka t. J Clin Med. 2022 Apr 17;11(8):2239. doi: 10.3390/jcm11082239. J Clin Med. 2022. PMID: 35456332 Free PMC article.
Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study.
Cybulska-Stopa B, Ługowska I, Jagodzińska-Mucha P, Koseła-Paterczyk H, Kozak K, Klimczak A, Świtaj T, Ziobro M, Roman A, Rajczykowski M, Suwiński R, Niemiec M, Zemełka T, Falkowski S, Rutkowski P. Cybulska-Stopa B, et al. Among authors: zemelka t. Postepy Dermatol Alergol. 2019 Oct;36(5):566-571. doi: 10.5114/ada.2018.79940. Epub 2019 Nov 12. Postepy Dermatol Alergol. 2019. PMID: 31839773 Free PMC article.
19 results